Outcomes for patients with metastatic HER2-positive breast cancer have improved as a result of research helping health care providers to understand the mechanisms of the protein, which has led to the ...
Hormone receptor (HR)-positive breast cancer has become well managed with effective treatments such as anti-hormonal therapies in both early and late-stage disease. However, it is important for ...
Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback